TETI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.757
EU - Europa 5.054
AS - Asia 1.303
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
AF - Africa 2
Totale 12.142
Nazione #
US - Stati Uniti d'America 5.735
IE - Irlanda 1.408
SE - Svezia 1.236
CN - Cina 1.222
IT - Italia 562
UA - Ucraina 532
DE - Germania 469
FI - Finlandia 255
PL - Polonia 188
GB - Regno Unito 161
FR - Francia 135
BE - Belgio 48
IN - India 36
RU - Federazione Russa 35
VN - Vietnam 23
CA - Canada 19
IR - Iran 8
CL - Cile 7
EU - Europa 6
HK - Hong Kong 6
AR - Argentina 5
CZ - Repubblica Ceca 4
AT - Austria 3
AU - Australia 3
LV - Lettonia 3
MX - Messico 3
RO - Romania 3
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
IL - Israele 2
JP - Giappone 2
NL - Olanda 2
PT - Portogallo 2
SG - Singapore 2
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
LI - Liechtenstein 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 12.142
Città #
Dublin 1.408
Chandler 1.128
Jacksonville 1.120
Nyköping 687
Shenzhen 447
Beijing 350
Ashburn 275
Messina 251
Dearborn 249
Princeton 243
Medford 235
Cambridge 234
Boardman 213
Des Moines 195
Ann Arbor 188
Warsaw 188
Woodbridge 80
Bremen 70
New York 63
Wilmington 57
Shenyang 55
Jinan 54
Brussels 48
San Mateo 47
Nanjing 33
Los Angeles 32
Pune 31
Lancaster 30
Haikou 29
Hebei 26
Tianjin 25
Ningbo 24
Dong Ket 23
Norwalk 22
Seattle 22
Zhengzhou 21
Helsinki 18
Rome 18
Taiyuan 18
Houston 16
Taizhou 16
Hangzhou 15
Milan 15
Nuremberg 14
Catania 13
Washington 13
Guangzhou 12
Clearwater 10
Fuzhou 10
Nanchang 10
Auburn Hills 9
Changsha 9
Ottawa 9
Leawood 8
Siracusa 8
Ardabil 7
Augusta 7
Hefei 7
Jiaxing 7
Lanzhou 7
Napoli 7
Pavia 7
Saint Petersburg 7
Falls Church 6
Hong Kong 6
Kemerovo 6
Modica 6
Riva 6
Tappahannock 6
Monmouth Junction 5
Novokuznetsk 5
Palermo 5
Piazza Armerina 5
Piraino 5
Santa Fe 5
Borghetto Santo Spirito 4
Edinburgh 4
Hanover 4
Kunming 4
Lappeenranta 4
Montréal 4
Brno 3
Jiutepec 3
London 3
Milazzo 3
Modugno 3
Naples 3
Nürnberg 3
Redwood City 3
Toronto 3
Turin 3
Verona 3
Vienna 3
Villa San Giovanni 3
Xiangfen 3
Bangalore 2
Bogotá 2
Brooklyn 2
Cairo 2
Camerino 2
Totale 8.642
Nome #
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments. 506
ATTIVAZIONE DI NLRP3 IMFLAMMASOMA NEL CORSO DELLE INFEZIONI SOSTENUTE DAGLI STREPTOCOCCHI DI GRUPPO B 145
Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection. 124
Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology 121
The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci 118
Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform 114
beta(2) integrins are involved in cytokine responses to whole Gram-positive bacteria 87
The dual role of innate immunity during influenza 84
Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor 83
Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant 81
VACCINE FORMULATIONS COMPRISING ANTIIDIOTYPIC ANTIBODIES WHICH IMMUNOLOGICALLY MIMIC GROUP B STREPTOCOCCAL CARBOHYDRATES 80
The Phagocyte, Metchnikoff, and the Foundation of Immunology 80
Caratterizzazione molecolare di glicoproteine criptococciche capaci di indurre risposte umorali. 78
Approccio proteomico per l’analisi comparativa del secretoma di coltura di S. agalactiae, ceppo Nem316 77
“Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor” 76
Protective activity of a protein fragment identified by the screening of a Streptococcus pneumoniae phage-displayed genomic library 76
Anti-idiotypic B5 single chain variable fragment [synthetic construct]. 75
A new surface protein of Streptococcus suis identified by proteomics 75
Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries 74
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. 73
Risposta dell'Ospite alle Infezioni Batteriche 72
Costruzione e screening di librerie “lambda display” da genoma completo di streptococchi patogeni per l’identificazione di prodotti genici che interagiscono con i tessuti dell’ospite. 72
Attivazione dell'inflammasoma da parte di S.pneumoniae 72
CXCL1/2 chemokines are newly synthesized by neutrophils and released at high levels after recognition of live Group B Streptococcus by means of endosomal Toll-like receptors 72
Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans 71
Bacteroides fragilis lipopolysaccharide activates cells via CD14/MD2/TLR4 69
CELL ACTIVATION INDUCED BY LIPOTEICHOIC ACID AND POLYSACCHARAIDES FRM STREPTOCOCCI. 69
La proteina FbsA di Streptococcus agalactiae è unimportante fattore di virulenza 69
NEUTROPHILS PRODUCE HIGH LEVELS OF CHEMOKINES (CXCL1/2) AFTER SENSING GROUP B STREPTOCOCCUS THROUGH ENDOSOMAL TLRS 69
PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of Group B Streptococcus 69
Analysis of the secretome of the group B Streptococcus 68
Anti-idiotypic vaccination against group B streptococci 67
Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library. 67
Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease 66
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection 66
Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen- Specific Libraries 66
Anti-idiotypic G1 single chain variable fragment [synthetic construct]. 65
MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans 65
Vaccinazione anti-idiotipica nei confronti di infezioni sperimsntali da Neisseria meningitidis di gruppo B con anticorpi ricombinanti immagini interne del polissacaride capsulare. 64
Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization 64
Immunoprotective activity of a Streptococcus pneumoniae protein identified by phage display. 64
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection 64
Yeast Killer Toxin-Like Candidacidal Ab6 Antibodies Elicited through the Manipulation of the Idiotypic Cascade 63
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci 62
Vaccinazione anti-idiotipica a DNA per l'induzione di anticorpi diretti contro il polissacaride di batteri capsulati. 61
Immunoprotective cryptococcal proteins 61
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes 61
Immunogenic mimics of Brucella lipopolysaccharide epitopes 61
Identificazione mediante “Phage Display” diframmenti biologicamente attivi della fibrinogenbinding protein A (FbsA) di Streptococcus agalactiae. 61
Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4 60
IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type I pattern during experimental cryptococcosis 60
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components 60
Sherris Microbiologia Medica 60
G(i) proteins regulate lipopolysaccharide and Staphylococcus aureus induced cytokine production but not (1 -> 3)-beta-D-glucan induced cytokine suppression 59
AGE-RELATED MORTALITY AND ADHERENT SPLENIC CELL MEDIATOR PRODUCTION TO ENDOTOXIN IN THE RAT 59
BETA-LACTAM ANTIBIOTICS (AZTREONAM, AMPICILLIN, CEFAZOLIN AND CEFTAZIDIME) IN THE CONTROL AND ERADICATION OF SALMONELLA- TYPHIMURIUM IN NATURALLY RESISTANT AND SUSCEPTIBLE MICE 59
Characterization of two novel Cryptococcal mannoproteins recognized by immune sera 59
A meeting of mimics. 59
Analysis of the Streptococcus agalactiae exoproteome. 59
The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/αvintegrin axis 59
Role of the TLR2/MYD88 activation pathway in group B streptococcal infections. 58
Ruolo dell'interluchina 18 nelle infezioni da streptococco di gruppo B. 58
Therapy of mucosal candidiasis by expression of an anti- idiotype in human commensal bacteria 58
CYTOKINE APPEARANCE AND EFFECTS OF ANTITUMOR NECROSIS FACTOR- ALPHA ANTIBODIES IN A NEONATAL RAT MODEL OF GROUP-B STREPTOCOCCAL INFECTION 58
Identification and cloning of a cryptococcal deacetylase that produces protective immune responses 58
PEPTIDES THAT MIMIC NON-HUMAN CROSS-REACTIVE PROTECTIVE EPITOPES OF THE GROUP B MENINGOCOCCAL CAPSULAR POLYSACCHARIDE 57
Immunità protettiva indotta da una glutamina sintetasi di Cryptococcus neoformans 57
ANTI-LIPOTEICHOIC ACID ANTIBODIES ENHANCE RELEASE OF CYTOKINES BY MONOCYTES SENSITIZED WITH LIPOTEICHOIC ACID 57
Tumor necrosis factor-inducing activities of Cryptococcus neoformans components (vol 64, pg 5199, 1996) 56
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease 56
Role of IL-10 in a neonatal mouse listeriosis model 56
Effect of nitric oxide donors and nitric oxide synthase inhibitors in neonatal rat endotoxic shock 55
Compositional analysis of the major capsular polysaccharides of Cryptococcus neoformans by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) 55
Plasminogen- and Fibronectin–Binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells. 55
New orientations in chemotherapy for gastric carcinoma 54
Selection of Neisseria meningitidis group B antigenic epitopes using lambda libraries. 54
Recognition of yeast nucleic acids triggers a host-protective type I interferon response 54
The IL-1b/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection 54
Essential role of interleukin-1 signaling in host defenses against group B streptococcus 54
Identification Of Microbial Proteins Involved In Interaction With ECM Proteins By Using Lambda-Display Libraries 53
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 53
Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock 53
Identification of major proteins secreted by Cryptococcus neoformans 53
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 53
Virus ed infezioni alimentari: il caso dell’epatite A 53
Uso del “phage display”per caratterizzare ilrepertorio anticorpale indotto da vaccinazione. 53
L'IFN-beta è fondamentale nel polarizzare la risposta citochinica verso il tipo 1 nel corso dell'infezione da cryptococcus neoformans. 52
c-Jun kinase is a critical signaling molecule in a neonatal model of group B streptococcal sepsis 52
Age-related sensitivity of neonatal mice to toxicity induced by heat-killed group B streptococci. 52
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells 52
Brucellosi:Aspetti medici e sociali 51
Cross reattività di una lipoproteina di Neisseriameningitidis con la proteina legante il fattore H (fHbp) 51
Studio delle vie di trasduzione del segnale coinvolte nell’induzione di IFN b da parte delle cDC infettate in vitro con Aspergillus fumigatus 51
Identification of fibrinogen binding protein fragments using genomic phage display libraries of Group B Streptococcus 51
Activation of the NLRP3 inflammasome by group B streptococci. 51
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice 51
Effects of anti-cytokine treatments in neonatal sepsis models 50
BENEFICIAL-EFFECTS OF INTERLEUKIN-6 IN NEONATAL MOUSE MODELS OF GROUP-B STREPTOCOCCAL DISEASE 50
Immunogenic and therapeutic compositions for streptococcus suis 50
NEUTROPHILS ARE MAINLY RESPONSIBLE FOR IL-1Β PRODUCTION DURING GROUP B STREPTOCOCCUS INFECTION 50
Totale 6.949
Categoria #
all - tutte 42.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 0 28
2019/20202.004 325 136 17 126 16 242 294 218 35 232 342 21
2020/20211.683 186 23 349 91 116 219 45 146 79 199 139 91
2021/20221.600 18 259 16 34 37 11 114 76 17 192 288 538
2022/20234.266 341 348 178 388 412 408 58 243 1.712 19 115 44
2023/20241.351 86 159 526 86 105 212 7 58 2 33 16 61
Totale 12.301